Evidence for the existence of high affinity binding sites for indomethacin on human blood platelets. 1986

R Magous, and J P Bali, and R Escale, and J P Girard, and E Rechencq, and J C Rossi

Using human blood-washed platelets and [3H]indomethacin, we demonstrated the presence of saturable, time- and temperature-dependent high affinity binding sites for non-steroidal anti-inflammatory drugs. The observed Kd value for indomethacin was 5 nM. Structural specificity of the non-steroidal anti-inflammatory drug site was studied with arylacetic acids, anthranilic acids, and compounds from other chemical families. Arylacetic acid drugs had affinities which were similar to the affinity of indomethacin. Affinity differences among the other drugs may be related to the presence or absence of the lipophilic substituent on the central ring. As expected, anti-inflammatory pyrrazole derivatives, aspirin, bucloxic acid, cortisol, nordihydroguaiaretic acid, and the chemotactic peptide formyl-Met-Leu-Phe were not recognized by the indomethacin binding site.

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D011955 Receptors, Drug Proteins that bind specific drugs with high affinity and trigger intracellular changes influencing the behavior of cells. Drug receptors are generally thought to be receptors for some endogenous substance not otherwise specified. Drug Receptors,Drug Receptor,Receptor, Drug
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014316 Tritium The radioactive isotope of hydrogen also known as hydrogen-3. It contains two NEUTRONS and one PROTON in its nucleus and decays to produce low energy BETA PARTICLES. Hydrogen-3,Hydrogen 3

Related Publications

R Magous, and J P Bali, and R Escale, and J P Girard, and E Rechencq, and J C Rossi
October 1979, European journal of pharmacology,
R Magous, and J P Bali, and R Escale, and J P Girard, and E Rechencq, and J C Rossi
March 1980, Life sciences,
R Magous, and J P Bali, and R Escale, and J P Girard, and E Rechencq, and J C Rossi
October 1994, Thrombosis research,
R Magous, and J P Bali, and R Escale, and J P Girard, and E Rechencq, and J C Rossi
May 1984, Biochemical and biophysical research communications,
R Magous, and J P Bali, and R Escale, and J P Girard, and E Rechencq, and J C Rossi
January 1978, Scandinavian journal of immunology,
R Magous, and J P Bali, and R Escale, and J P Girard, and E Rechencq, and J C Rossi
April 1982, Hoppe-Seyler's Zeitschrift fur physiologische Chemie,
R Magous, and J P Bali, and R Escale, and J P Girard, and E Rechencq, and J C Rossi
July 1980, Analytical biochemistry,
R Magous, and J P Bali, and R Escale, and J P Girard, and E Rechencq, and J C Rossi
March 1979, Cellular immunology,
R Magous, and J P Bali, and R Escale, and J P Girard, and E Rechencq, and J C Rossi
March 1984, The Journal of clinical investigation,
R Magous, and J P Bali, and R Escale, and J P Girard, and E Rechencq, and J C Rossi
September 1984, Biochemical pharmacology,
Copied contents to your clipboard!